Thanks for the post! Great read!
Besides the quote you provided, I like this:
My hope is that we will certainly retain some of the important innovation pathways where we add value. Let me give you an example in relation to personalized immunotherapies. Because the U.K.’s health ecosystem is joined up, we're able to bring clinicians and health care organization leaders into the regulatory discussions.
And this:
We committed fully to the goals of addressing health data governance internationally and grasping the opportunities of use of real-world data to enhance regulatory decision-making, including evidence generation in areas where there are data ‘deserts’
Bottom line, MHRA’s Approval is going to be STUNNING!!!